2008
DOI: 10.4321/s0004-06142008000100005
|View full text |Cite
|
Sign up to set email alerts
|

Litiasis medicamentosa en pacientes VIH + en tratamiento con Indinavir

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2011
2011
2017
2017

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 12 publications
0
2
0
1
Order By: Relevance
“…As indinavir is poorly soluble at pH 45, urinary acidification, increased fluid intake, and, if possible, discontinuation of therapy may dissolve stones. [119][120][121][122][123][124] Other medications precipitating in the urine but rarely causing stones include ceftriaxone, sulfonamides, ampicillin, amoxicillin, triamteren, acyclovir, and oxypurine.…”
Section: Urinary Tract Infectionsmentioning
confidence: 99%
“…As indinavir is poorly soluble at pH 45, urinary acidification, increased fluid intake, and, if possible, discontinuation of therapy may dissolve stones. [119][120][121][122][123][124] Other medications precipitating in the urine but rarely causing stones include ceftriaxone, sulfonamides, ampicillin, amoxicillin, triamteren, acyclovir, and oxypurine.…”
Section: Urinary Tract Infectionsmentioning
confidence: 99%
“…Patients with chronic hepatitis C coinfection have a greater risk of lithiases. Indinavir-associated calculi are very small (2-6 mm) and they are usually eliminated, but tubular deposition may cause post-renal obstructive failure [4][5][6]. Ganciclovir is also nephrotoxic and it produces intratubular crystal precipitation.…”
Section: Discussionmentioning
confidence: 99%
“…Com a introdução de novos e potentes inibidores de proteases para o tratamento do HIV observou-se significante redução da mortalidade com concomitante aumento na sobrevida dos pacientes infectados. No entanto, têm-se descrito vários efeitos secundários em seres humanos associados ao uso destes medicamentos como a resistência à insulina (CARON et al, 2001), nefropatias, litíase, aumento do risco de infarto do miocárdio (NOOR et al, 2002;COLLIN et al, 2007;ESCUDERO et al, 2008), entre doenças cardíacas dado por efeitos secundários como a hiperlipidemia, lipodistrofia (redistribuição anormal da gordura corporal), diminuição dos níveis séricos de HDL (CALZA et al, 2004), entre outros.…”
Section: Discussionunclassified